PT2257309T - Conjugados rgd-(bacterio)clorofila para utilização no diagnóstico de tumores compreendendo domínios necróticos - Google Patents
Conjugados rgd-(bacterio)clorofila para utilização no diagnóstico de tumores compreendendo domínios necróticosInfo
- Publication number
- PT2257309T PT2257309T PT97141915T PT09714191T PT2257309T PT 2257309 T PT2257309 T PT 2257309T PT 97141915 T PT97141915 T PT 97141915T PT 09714191 T PT09714191 T PT 09714191T PT 2257309 T PT2257309 T PT 2257309T
- Authority
- PT
- Portugal
- Prior art keywords
- bacterio
- rgd
- chlorophyll
- conjugates
- tumors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K51/0451—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. phorphine derivatives, bilirubin, biliverdine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6429808P | 2008-02-27 | 2008-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2257309T true PT2257309T (pt) | 2020-01-22 |
Family
ID=40677556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97141915T PT2257309T (pt) | 2008-02-27 | 2009-03-01 | Conjugados rgd-(bacterio)clorofila para utilização no diagnóstico de tumores compreendendo domínios necróticos |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8815213B2 (https=) |
| EP (2) | EP2257309B1 (https=) |
| JP (1) | JP5620279B2 (https=) |
| KR (1) | KR101595138B1 (https=) |
| CN (1) | CN102036684B (https=) |
| AU (1) | AU2009219682B2 (https=) |
| BR (1) | BRPI0907791A2 (https=) |
| CA (1) | CA2717060C (https=) |
| DK (1) | DK2257309T3 (https=) |
| ES (1) | ES2764781T3 (https=) |
| MX (1) | MX2010009530A (https=) |
| PT (1) | PT2257309T (https=) |
| RU (1) | RU2518296C2 (https=) |
| WO (1) | WO2009107139A1 (https=) |
| ZA (1) | ZA201006789B (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007075565A2 (en) * | 2005-12-16 | 2007-07-05 | Shachaf Catherine M | Diagnostic system for the detection and diagnosis of skin cancer |
| US9957293B2 (en) * | 2006-08-23 | 2018-05-01 | Yeda Research And Development Company Ltd. | Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| WO2011020107A2 (en) * | 2009-08-14 | 2011-02-17 | Georgetown University | Compositions and methods for detection and treatment of breast cancer |
| PL219569B1 (pl) | 2010-02-19 | 2015-05-29 | Peptaderm Spółka Z Ograniczoną Odpowiedzialnością | Cykliczne tetrapeptydy i ich zastosowanie |
| US8524239B2 (en) | 2010-07-09 | 2013-09-03 | The United States of America as represented by the Secrectary, Department of Health and Human Services | Photosensitizing antibody-fluorophore conjugates |
| KR101253709B1 (ko) * | 2011-06-02 | 2013-04-12 | 경북대학교 산학협력단 | 분비형 표적 추적 융합 단백질 |
| JP5904602B2 (ja) | 2011-09-05 | 2016-04-13 | 一般財団法人バイオダイナミックス研究所 | 高分子型蛍光分子プローブ |
| CN104303184B (zh) * | 2012-03-21 | 2018-05-15 | 皇家飞利浦有限公司 | 整合医疗成像和活检数据的临床工作站以及使用其的方法 |
| CN103705532B (zh) * | 2012-10-08 | 2016-09-14 | 浙江海正药业股份有限公司 | 靶向胸苷激酶光敏剂及其药物组合物与治疗癌症的用途 |
| CN106573054B (zh) * | 2014-06-02 | 2021-04-13 | 乐天医药生技股份有限公司 | 酞菁探针及其用途 |
| SG11201610052TA (en) | 2014-08-08 | 2017-02-27 | Us Health | Photo-controlled removal of targets in vitro and in vivo |
| JP6882978B2 (ja) | 2014-10-29 | 2021-06-02 | バイスクルアールディー・リミテッド | Ｍｔ１−ｍｍｐに特異的な二環性ペプチドリガンド |
| WO2016090471A1 (en) * | 2014-12-08 | 2016-06-16 | University Health Network | System and method for enhanced mass spectrometry imaging |
| HUE051161T2 (hu) * | 2014-12-19 | 2021-03-01 | Bracco Imaging Spa | Operáció közbeni képalkotás |
| AU2016271853B2 (en) * | 2015-06-03 | 2020-10-22 | Surgimab S.A.S. | Fluorescent conjugates |
| AU2016308286B2 (en) | 2015-08-18 | 2022-04-07 | Rakuten Medical, Inc. | Phthalocyanine dye conjugates and their storage |
| WO2017049403A1 (en) | 2015-09-22 | 2017-03-30 | University Health Network | System and method for optimized mass spectrometry analysis |
| WO2018115203A1 (en) * | 2016-12-23 | 2018-06-28 | Bicyclerd Limited | Peptide derivatives having novel linkage structures |
| JP7387440B2 (ja) * | 2016-12-23 | 2023-11-28 | バイスクルテクス・リミテッド | Ｍｔ１－ｍｍｐに結合するためのペプチドリガンド |
| US10933134B2 (en) | 2017-03-16 | 2021-03-02 | Memorial Sloan Kettering Cancer Center | Combination therapies for treatment of cancer |
| JP7301757B2 (ja) | 2017-06-26 | 2023-07-03 | バイスクルアールディー・リミテッド | 検出可能部分を持つ二環式ペプチドリガンドおよびその使用 |
| CN111183147B (zh) | 2017-08-04 | 2024-07-05 | 拜斯科技术开发有限公司 | Cd137特异性的双环肽配体 |
| CA3072418A1 (en) * | 2017-08-08 | 2019-02-14 | Board Of Trustees Of Michigan State University | Tunable luminescent organic salts for enhanced imaging and photodynamic therapy |
| JP6920931B2 (ja) * | 2017-09-01 | 2021-08-18 | 富士フイルム株式会社 | 医療画像処理装置、内視鏡装置、診断支援装置、及び、医療業務支援装置 |
| JP2021514953A (ja) | 2018-02-23 | 2021-06-17 | バイスクルテクス・リミテッド | 多量体二環式ペプチドリガンド |
| IL279489B2 (en) | 2018-06-22 | 2025-10-01 | Bicycletx Ltd | Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate |
| RU2700407C1 (ru) * | 2018-07-23 | 2019-09-16 | Михаил Тимофеевич Александров | Способ лечения опухолевых и воспалительных заболеваний с применением фотодинамической терапии |
| CN111171030B (zh) * | 2018-11-12 | 2022-11-22 | 浙江海正药业股份有限公司 | 细菌叶绿素衍生物及其制备方法 |
| GB201820325D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for psma |
| GB201820295D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for MT1-MMP |
| GB201820288D0 (en) | 2018-12-13 | 2019-01-30 | Bicycle Tx Ltd | Bicycle peptide ligaands specific for MT1-MMP |
| JP2022514618A (ja) | 2018-12-21 | 2022-02-14 | バイスクルテクス・リミテッド | Ｐｄ－ｌ１に特異的な二環式ペプチドリガンド |
| US12551567B2 (en) | 2018-12-21 | 2026-02-17 | Bicyclerd Limited | Bicyclic peptide ligands specific for PD-L1 |
| GB201900529D0 (en) | 2019-01-15 | 2019-03-06 | Bicycletx Ltd | Bicyclic peptide ligands specific for CD38 |
| TWI860386B (zh) | 2019-07-30 | 2024-11-01 | 英商拜西可泰克斯有限公司 | 異質雙環肽複合物 |
| EP4070232A4 (en) * | 2019-12-05 | 2024-01-31 | Tempus Labs, Inc. | SYSTEMS AND METHODS FOR HIGH-THROUGHPUT ACTIVE SCREENING |
| IL300248A (en) | 2020-08-03 | 2023-03-01 | Bicycletx Ltd | peptide-based linkers |
| CN112933252A (zh) * | 2021-01-28 | 2021-06-11 | 厦门大学附属翔安医院 | 一种乳腺癌特异靶向分子探针及其制备方法和应用 |
| CN115466311A (zh) * | 2021-06-10 | 2022-12-13 | 首都医科大学 | 抗粘附迁移和侵袭的18β-甘草次酸-RGDK,其合成,抗癌转移活性和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4121876A1 (de) | 1991-07-02 | 1993-01-14 | Scheer Hugo | Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung |
| ATE158589T1 (de) | 1991-11-22 | 1997-10-15 | Yeda Res & Dev | Nicht-peptidische surrogate der arg-gly-asp sequenz und entsprechende pharmazeutische zusammensetzungen |
| IL102645A (en) * | 1992-07-26 | 1998-02-22 | Yeda Res & Dev | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| US6147195A (en) | 1993-07-26 | 2000-11-14 | Yeda Research And Development Co., Ltd. | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| US5789433A (en) * | 1995-01-17 | 1998-08-04 | Quadra Logic Technologies, Inc. | Green porphyrins as immunomodulators |
| IL116126A0 (en) | 1995-11-24 | 1996-01-31 | Yeda Res & Dev | Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them |
| EP0927045B1 (en) | 1996-09-10 | 2005-12-14 | The Burnham Institute | Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| US6576239B1 (en) | 1996-09-10 | 2003-06-10 | The Burnham Institute | Angiogenic homing molecules and conjugates derived therefrom |
| DE19756773A1 (de) * | 1997-12-19 | 1999-06-24 | Dade Behring Marburg Gmbh | Neues Verfahren und Diagnosemittel zur Hämostase-Diagnostik |
| ATE347554T1 (de) | 1998-12-09 | 2006-12-15 | Yeda Res & Dev | Palladiumsubstituierte bakteriochlorophyllderivate und deren verwendung |
| IL133253A0 (en) | 1999-12-01 | 2001-04-30 | Yeda Res & Dev | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| US7045117B2 (en) | 1999-12-01 | 2006-05-16 | Yeda Research And Development Co. Ltd. | Method for tumor diagnosis comprising administering of palladium-substituted bacteriochlorophyll derivatives |
| IL152900A0 (en) | 2002-11-17 | 2003-06-24 | Yeda Res & Dev | Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses |
| ZA200700169B (en) | 2004-06-07 | 2008-05-28 | Yeda Res & Dev | Cationic bacteriochlorophyll derivatives and uses thereof |
| AU2007244705A1 (en) * | 2006-04-27 | 2007-11-08 | Barnes-Jewish Hospital | Detection and imaging of target tissue |
| PT2061512T (pt) | 2006-08-23 | 2020-01-14 | Yeda Res & Dev | Conjugados de péptidos com rgd e fotossensibilizantes de (bacterio)clorofila e as suas utilizações |
| JP2010539163A (ja) * | 2007-09-14 | 2010-12-16 | ヘルス リサーチ インコーポレイテッド | 腫瘍イメージング及び治療用のマルチモーダル剤 |
-
2009
- 2009-03-01 AU AU2009219682A patent/AU2009219682B2/en not_active Ceased
- 2009-03-01 EP EP09714191.5A patent/EP2257309B1/en active Active
- 2009-03-01 CN CN200980115901.2A patent/CN102036684B/zh not_active Expired - Fee Related
- 2009-03-01 WO PCT/IL2009/000228 patent/WO2009107139A1/en not_active Ceased
- 2009-03-01 BR BRPI0907791-0A patent/BRPI0907791A2/pt not_active Application Discontinuation
- 2009-03-01 MX MX2010009530A patent/MX2010009530A/es active IP Right Grant
- 2009-03-01 RU RU2010139461/15A patent/RU2518296C2/ru active
- 2009-03-01 JP JP2010548248A patent/JP5620279B2/ja not_active Expired - Fee Related
- 2009-03-01 EP EP13186941.4A patent/EP2712627A3/en not_active Withdrawn
- 2009-03-01 DK DK09714191.5T patent/DK2257309T3/da active
- 2009-03-01 US US12/920,088 patent/US8815213B2/en active Active
- 2009-03-01 PT PT97141915T patent/PT2257309T/pt unknown
- 2009-03-01 CA CA2717060A patent/CA2717060C/en not_active Expired - Fee Related
- 2009-03-01 ES ES09714191T patent/ES2764781T3/es active Active
- 2009-03-01 KR KR1020107021381A patent/KR101595138B1/ko not_active Expired - Fee Related
-
2010
- 2010-09-22 ZA ZA2010/06789A patent/ZA201006789B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011513298A (ja) | 2011-04-28 |
| MX2010009530A (es) | 2010-11-30 |
| RU2518296C2 (ru) | 2014-06-10 |
| EP2712627A3 (en) | 2014-04-16 |
| AU2009219682B2 (en) | 2015-06-18 |
| EP2712627A2 (en) | 2014-04-02 |
| KR101595138B1 (ko) | 2016-02-18 |
| DK2257309T3 (da) | 2020-01-20 |
| ES2764781T3 (es) | 2020-06-04 |
| EP2257309A1 (en) | 2010-12-08 |
| KR20100127798A (ko) | 2010-12-06 |
| CN102036684B (zh) | 2017-06-09 |
| EP2257309B1 (en) | 2019-10-16 |
| CA2717060A1 (en) | 2009-09-03 |
| WO2009107139A1 (en) | 2009-09-03 |
| CA2717060C (en) | 2016-11-01 |
| RU2010139461A (ru) | 2012-04-10 |
| AU2009219682A1 (en) | 2009-09-03 |
| US20110064658A1 (en) | 2011-03-17 |
| ZA201006789B (en) | 2012-01-25 |
| JP5620279B2 (ja) | 2014-11-05 |
| CN102036684A (zh) | 2011-04-27 |
| US8815213B2 (en) | 2014-08-26 |
| BRPI0907791A2 (pt) | 2015-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2257309T (pt) | Conjugados rgd-(bacterio)clorofila para utilização no diagnóstico de tumores compreendendo domínios necróticos | |
| PT2426148E (pt) | Anticorpo anti-rá-il-3 para se utilizar no tratamento de tumores do sangue | |
| BRPI0921321A2 (pt) | métodos para o tratamento de indwcções e tumores | |
| PL2338519T3 (pl) | Środek do leczenia zwłóknienia szpiku | |
| BRPI1008566A2 (pt) | métodos e composições para o diagnóstico e tratamento de câncer | |
| BRPI0822560A2 (pt) | Instrumento para aplicações endoscópicas ou semelhantes | |
| SMT201500206B (it) | Composti spiro-ossindolici e loro uso come agenti terapeutici | |
| DK2121139T3 (da) | Formulations for cancer treatment | |
| BRPI1016234A2 (pt) | dispositivo aplicador para uso médico e/ou cosmético. | |
| BRPI0919979A2 (pt) | formulações de moléculas de ligação de antígeno de domínio único | |
| BRPI0919238A2 (pt) | métodos e composições para o tratamento de câncer | |
| BRPI0812753A2 (pt) | Combinações de substância ativas acaricidas | |
| BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
| BRPI0912683A2 (pt) | tratamento de tumores metastáticos | |
| IL220386B (en) | Compositions for the liquidation of tumors and uses thereof | |
| BRPI0922233A2 (pt) | compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas. | |
| BRPI0906444A2 (pt) | Compostos de 4-piridinona e seu uso para câncer | |
| BRPI0914683A2 (pt) | dispositivo para terapia de campo magnético | |
| LT3011975T (lt) | Kietoji kompozicija, skirta dažiklio vartojimui per burną ir jos diagnostinis panaudojimas | |
| BRPI0922884A2 (pt) | compostos para tratamento de câncer | |
| EP2340851A4 (en) | DIAGNOSTIC METHOD AND THERAPEUTIC METHOD FOR CANCER | |
| HUE036490T2 (hu) | Tumorok kezelése anti-L1 antitest alkalmazásával | |
| BRPI0921935A2 (pt) | composições adesivas de uso médico | |
| SI2340271T1 (sl) | Konjugati polimer-bioaktivnega sredstva | |
| EP2283862A4 (en) | ANTITUMOR AGENT |